serotonin syndrome ss group symptoms may occur use certain serotonergic medications symptoms range mild severe potentially symptoms mild cases include high blood pressure fast heart rate usually without symptoms moderate cases include high body temperature agitation increased reflexes tremor sweating dilated pupils severe cases body temperature increase greater complications may include seizures extensive muscle serotonin syndrome typically caused use two serotonergic medications may include selective serotonin reuptake inhibitor ssri serotonin norepinephrine reuptake inhibitor snri monoamine oxidase inhibitor maoi tricyclic antidepressants tcas amphetamines pethidine meperidine tramadol dextromethorphan buspirone ltryptophan st johns wort triptans ecstasy mdma metoclopramide occurs ssri predictable consequence excess serotonin central nervous onset symptoms typically within day extra diagnosis based persons symptoms history medication conditions produce similar symptoms neuroleptic malignant syndrome malignant hyperthermia anticholinergic toxicity heat stroke meningitis ruled laboratory tests confirm initial treatment consists discontinuing medications may agitated benzodiazepines may sufficient serotonin antagonist cyproheptadine may high body temperature active cooling measures may number cases ss occur year appropriate medical intervention risk death low likely less highprofile case libby zion generally accepted died ss resulted changes graduate medical school education new york symptom onset usually relatively rapid ss encompasses wide range clinical findings mild symptoms may consist increased heart rate shivering sweating dilated pupils myoclonus intermittent jerking twitching well overresponsive many symptoms may side effects drug drug interaction causing excessive levels serotonin rather effect elevated serotonin tremor common side effect mdmas action dopamine whereas hyperreflexia symptomatic exposure serotonin agonists moderate intoxication includes additional abnormalities hyperactive bowel sounds high blood pressure hyperthermia temperature high overactive reflexes clonus moderate cases may greater lower limbs upper limbs mental changes include hypervigilance insomnia severe symptoms include severe increases heart rate blood pressure temperature may rise lifethreatening cases abnormalities include metabolic acidosis rhabdomyolysis seizures kidney failure disseminated intravascular coagulation effects usually arising consequence symptoms often present clinical triad numerous medications street drugs cause ss taken alone high doses combination serotonergic agents table lists many cases serotonin toxicity occur people ingested drug combinations synergistically increase synaptic may also occur due overdose single serotonergic combination monoamine oxidase inhibitors maois precursors ltryptophan pose particularly acute risk lifethreatening serotonin case combination maois tryptamine agonists commonly known ayahuasca present similar dangers combination precursors phenomenon described general terms cheese effect many maois irreversibly inhibit monoamine oxidase take least four weeks enzyme replaced body instance irreversible respect tricyclic antidepressants clomipramine imipramine risk causing many medications may incorrectly thought cause ss example case reports implicated atypical antipsychotics ss appears based pharmacology unlikely cause also suggested mirtazapine significant serotonergic effects therefore dual action bupropion also suggested cause although evidence significant serotonergic activity thought unlikely produce us food drug administration fda issued alert suggesting combined use ssris snris triptan medications sibutramine could potentially lead severe cases disputed researchers none cases reported fda met hunter criteria condition however occurred surprising clinical situations phenotypic variations among individuals associated unexpected drugs including relative risk severity serotonergic side effects serotonin toxicity individual drugs combinations complex ss reported patients ages including elderly children even newborn infants due utero serotonergic toxicity ssris increases dose even overdose insufficient cause fatalities ss healthy elevations central nervous system cns serotonin typically reach potentially fatal levels drugs different mechanisms action mixed various drugs ssris also clinically significant potency serotonin reuptake inhibitors tramadol amphetamine mdma associated severe cases although significant health risk associated opioid overdoses respiratory still possible individual develop ss certain opioids without loss consciousness however cases opioidrelated ss involve concurrent use serotergenic drug nonetheless uncommon individuals taking opioids also taking antidepressants due comorbidity pain cases opioids alone cause ss typically seen tramadol dual mechanism serotoninnorepinephrine reuptake ss caused tramadol particularly problematic individual taking drug unaware risks associated attempts selfmedicate symptoms headache agitation tremors opioids exacerbating condition serotonin neurotransmitter involved multiple complex biological processes including aggression pain sleep appetite anxiety depression migraine humans effects excess serotonin first noted patients receiving maoi syndrome caused increased serotonin originally suspected agonism receptors central grey nuclei medulla responsible development study determined overstimulation primarily receptors appears contribute substantially receptor may still contribute pharmacodynamic interaction increased synaptic concentrations serotonin agonist saturate receptor additionally noradrenergic cns hyperactivity may play role cns norepinephrine concentrations increased ss levels appear correlate clinical outcome neurotransmitters may also play role nmda receptor antagonists Î³aminobutyric acid suggested affecting development serotonin toxicity pronounced following supratherapeutic doses overdoses merge continuum toxic effects postulated spectrum concept serotonin toxicity emphasises role progressively increasing serotonin levels play mediating clinical picture side effects merge toxicity doseeffect relationship effects progressive elevation serotonin either raising dose one drug combining another serotonergic drug may produce large elevations serotonin experts prefer terms serotonin toxicity serotonin toxidrome accurately reflect form specific test ss diagnosis symptom observation investigation persons several criteria proposed first evaluated criteria introduced harvey researchers later developed hunter toxicity criteria decision rules better sensitivity specificity respectively compared gold standard diagnosis medical sternbachs criteria still commonly important symptoms diagnosing ss tremor extreme aggressiveness akathisia clonus spontaneous inducible physical examination patient include assessment deep tendon reflexes muscle rigidity dryness mucosa mouth size reactivity pupils intensity bowel sounds skin color presence absence patients history also plays important role diagnosis investigations include inquiries use prescription overthecounter drugs illicit substances dietary supplements agents implicated development fulfill hunter criteria patient must taken serotonergic agent meet one following serotonin toxicity characteristic picture generally hard confuse medical conditions situations may go unrecognized may mistaken viral illness anxiety disorders neurological disorder anticholinergic poisoning sympathomimetic toxicity worsening psychiatric condition often confused serotonin syndrome neuroleptic malignant syndrome clinical features neuroleptic malignant syndrome ss share features make differentiating conditions autonomic dysfunction altered mental status however actually different conditions different underlying dysfunction serotonin excess vs dopamine blockade time course clinical features nms differ significantly serotonin serotonin toxicity rapid onset administration serotonergic drug responds serotonin blockade drugs like chlorpromazine cyproheptadine dopamine receptor blockade nms slow onset typically evolves several days administration neuroleptic drug responds dopamine agonists differential diagnosis may become difficult patients recently exposed serotonergic neuroleptic drugs bradykinesia extrapyramidal lead pipe rigidity classically present nms whereas ss causes hyperkinesia clonus distinct symptoms aid management based primarily stopping usage precipitating drugs administration serotonin antagonists cyproheptadine regimen mg initial dose followed mg every hours supportive care including control agitation control autonomic instability control additionally ingest large doses serotonergic agents may benefit gastrointestinal decontamination activated charcoal administered within hour intensity therapy depends severity symptoms symptoms mild treatment may consist discontinuation offending medication medications offering supportive measures giving benzodiazepines myoclonus waiting symptoms resolve moderate cases thermal cardiorespiratory abnormalities corrected benefit serotonin antagonists serotonin antagonist cyproheptadine recommended initial therapy although controlled trials demonstrating efficacy despite absence controlled trials number case reports detailing apparent improvement people administered animal experiments also suggest benefit serotonin cyproheptadine available tablets therefore administered orally via nasogastric tube unlikely effective people administered activated charcoal limited use severe cyproheptadine stopped person longer experiencing symptoms half life serotonergic medications already additional pharmacological treatment severe case includes administering atypical antipsychotic drugs serotonin antagonist activity critically ill people receive therapies well sedation neuromuscular people autonomic instability low blood pressure require treatment directacting sympathomimetics epinephrine norepinephrine conversely hypertension tachycardia treated shortacting antihypertensive drugs nitroprusside esmolol longer acting drugs propranolol avoided may lead hypotension cause serotonin toxicity accumulation important factor determining course treatment serotonin catabolized monoamine oxidase presence oxygen care taken prevent unsafe spike body temperature metabolic acidosis oxygenation assist dispatching excess serotonin principle applies alcohol intoxication cases ss caused maois oxygenation help dispatch serotonin instances hydration main concern enzyme regenerated specific treatment symptoms may required one important treatments control agitation due extreme possibility injury person caregivers benzodiazepines administered first sign physical restraints recommended agitation delirium may contribute mortality enforcing isometric muscle contractions associated severe lactic acidosis hyperthermia physical restraints necessary severe agitation must rapidly replaced pharmacological agitation cause large amount muscle breakdown breakdown cause severe damage kidneys condition called treatment hyperthermia includes reducing muscle overactivity via sedation benzodiazepine severe cases may require muscular paralysis vecuronium intubation artificial suxamethonium recommended muscular paralysis may increase risk cardiac dysrhythmia hyperkalemia associated antipyretic agents recommended increase body temperature due muscular activity hypothalamic temperature set point upon discontinuation serotonergic drugs cases ss resolve within although cases delirium may persist number symptoms typically persist longer time frame patients taking drugs long elimination halflife active metabolites protracted duration cases reported persisting chronic antidepressant discontinuation may contribute ongoing following appropriate medical management ss generally associated favorable epidemiological studies ss difficult many physicians unaware diagnosis may miss syndrome due variable survey conducted england found general practitioners prescribed antidepressant nefazodone unaware incidence may increasing larger number proserotonergic drugs drugs increase serotonin levels used clinical one postmarketing surveillance study identified incidence cases per patientmonths patients taking additionally around persons overdose ssris thought develop widely recognized example ss death libby zion zion freshman bennington college death march age died within hours emergency admission new york hospital cornell medical center ongoing history depression came manhattan hospital evening march fever agitation strange jerking motions body also seemed disoriented times emergency room physicians unable diagnose condition definitively admitted hydration observation death caused combination pethidine medical intern prescribed case influenced graduate medical education residency work hours limits set working hours medical postgraduates commonly referred interns residents hospital training programs also require closer senior physician disease httpsenwikipediaorgwikiserotoninsyndrome